AMRN:NASDAQ
Amarin Corporation PLC
$12.16
arrow_upward
+0.58%(+0.070) 1D
Oct 6, 11:32:58 AM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for AMRN...
Open
$12.09
High
$12.19
Low
$11.83
Mkt. cap
263.02M
Avg. vol.
77.26K
Volume
21.44K
52-wk high
$20.90
52-wk low
$11.83
EPS
-$1.30
Beta
0.76
Shares outstanding
21.12M
No. of employees
80
Open
$12.09
High
$12.19
Low
$11.83
Mkt. cap
263.02M
Avg. vol.
77.26K
Volume
21.44K
52-wk high
$20.90
52-wk low
$11.83
EPS
-$1.30
Beta
0.76
Shares outstanding
21.12M
No. of employees
80
News stories
From web sources and news partners
Seeking Alpha
·
30 minutes ago
25 stocks up more than +100% in 2026 as the S&P 500 hits record high
Investing News Network
·
3 minutes ago
NYSE Texas Delivers White Paper to Highlight its Mission: NYSE Content Update
Breakingthenews.net
·
7 minutes ago
US extends gains, Dow rises 400 pts
NBC News
·
1 hour ago
S&P 500 hits record high as Nvidia nears $6 trillion milestone
Profile
Amarin Corporation is an Irish-American biopharmaceutical company founded in 1993 and headquartered in Dublin, Ireland and Bridgewater, New Jersey. The company develops and markets medicines for the treatment of cardiovascular disease. It has developed the drug Vascepa, a prescription grade omega-3 fatty acid.
In July 2012, their lead-candidate drug named Vascepa received FDA-approval, competing against GlaxoSmithKline's Lovaza. Wikipedia
About Amarin Corporation PLC
CEO-
Employees80
FoundedMar 1, 1989
HeadquartersDublin, Leinster, Ireland
SectorBiotechnology
Websiteamarincorp.com